Youjin Choi


Youjin Choi


New York | 1095 Avenue of the Americas, New York, NY 10036-6797
+1 212 641 5686 | +1 212 698 3599

| vCard | PDF

Practice Areas

Youjin Choi focuses her practice on corporate and securities matters. She has particular experience advising on domestic and cross-border merger and acquisitions, venture capital investments and capital markets transactions.

Ms. Choi was a Dechert summer associate in 2012.


Significant Experience

  • Forward Pharma A/S in its US$235 million initial public offering and listing on NASDAQ.
  • Onxeo SA (f/k/a BioAlliance Pharma SA), a biopharmaceutical company dedicated to the development of orphan oncology products, in its licensing agreement with Innocutis Holding LLC over the commercialization of Sitavig® in North America.
  • Resource Label Group, LLC, a leading manufacturer of pressure sensitive labels, in its acquisition of Taylor Made Labels, Inc., a premier pressure sensitive label manufacturer and design firm with flexographic and digital printing capabilities focused on the food, fresh produce, wine and beverage market segments.
  • OCI Enterprises Inc., the North American subsidiary of OCI Company Ltd. of Seoul, Korea, in the proposed sale of its approximately 73% limited partner interest in OCI Resources LP (NYSE: OCIR), as well as its 2% general partner interest and related incentive distribution rights, to Park Holding A.S., a subsidiary of Ciner Group of Istanbul, Turkey.
  • University of Virginia, B.A., Economics and Psychology, 2006, with Distinction, Phi Beta Kappa
  • Cornell Law School, J.D., 2013, General Editor of the Cornell International Law Journal
  • New York
  • Korean